DS-8201a

trastuzumab deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for DS-8201a, covering 2020-02-17 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer [Phase 1]